| Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024 |
Globe Newswire |
06/18 |
16:00 |
| Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting |
Globe Newswire |
06/18 |
16:00 |
| Red Gold Modernizes Dock Scheduling, Transportation Management, and LTL Process with Loadsmart |
Globe Newswire |
06/18 |
16:00 |
| First Onsite expands in Virginia with new branch in Roanoke |
Globe Newswire |
06/18 |
16:00 |
| Jess King Partners With Fabrik to Launch ‘On The Record’ |
Globe Newswire |
06/18 |
16:00 |
| Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference |
Globe Newswire |
06/18 |
16:00 |
| Analysis of INPEFA® (Sotagliflozin) Cost-Effectiveness Published in JACC: Heart Failure, the Peer-Reviewed Journal of the American College of Cardiology |
Globe Newswire |
06/18 |
16:00 |
| BairesDev CEO Nacho De Marco Wins Ernst & Young’s Entrepreneur Of The Year® 2024 Bay Area Award |
Globe Newswire |
06/18 |
16:00 |
| Salsify Names Piyush Chaudhari as New CEO |
Globe Newswire |
06/18 |
16:00 |
| Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial |
Globe Newswire |
06/18 |
16:00 |
| Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024 |
Globe Newswire |
06/18 |
16:00 |
| Erasca Initiates SEACRAFT-2 Pivotal Phase 3 Trial Evaluating Naporafenib Plus Trametinib in Patients with NRAS-Mutant Melanoma |
Globe Newswire |
06/18 |
16:00 |
| Powerdyne International Inc. Begins Preliminary Talks with an AI Motor Manufacturer for a Potential Acquisition or Merger |
Globe Newswire |
06/18 |
16:00 |
| ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit |
Globe Newswire |
06/18 |
16:00 |
| $150M Boost for Huntress Powers New Products in Escalating Fight to Secure Backbone of Global Economy |
Globe Newswire |
06/18 |
15:59 |
| VORAGO Rad-Hard MCU Enables In-Flight Reconfiguration of AMD Space-Grade FPGAs |
Globe Newswire |
06/18 |
15:50 |
| Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI) |
Globe Newswire |
06/18 |
15:35 |
| The Cluster Yachting Monaco celebrates the 10th anniversary at the Yacht Club de Monaco |
Globe Newswire |
06/18 |
15:33 |
| Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder |
Globe Newswire |
06/18 |
15:30 |
| America’s Car-Mart Reports Fourth Quarter and Fiscal Year 2024 Results |
Globe Newswire |
06/18 |
15:30 |
| Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders |
Globe Newswire |
06/18 |
15:30 |
| Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association’s Scientific Sessions |
Globe Newswire |
06/18 |
15:30 |
| Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome |
Globe Newswire |
06/18 |
15:30 |
| The Habit Burger Grill Opens 11th Restaurant in New Jersey With Hamilton Drive-Thru Location |
Globe Newswire |
06/18 |
15:30 |
| Super Hi Reports Unaudited Financial Results for the First Quarter of 2024 |
Globe Newswire |
06/18 |
15:30 |
